InvestorsHub Logo
Followers 50
Posts 5377
Boards Moderated 0
Alias Born 07/03/2020

Re: Investor2014 post# 277846

Thursday, 10/22/2020 11:55:03 AM

Thursday, October 22, 2020 11:55:03 AM

Post# of 458335

https://www.bio.org/sites/default/files/legacy/bioorg/docs/Clinical%20Development%20Success%20Rates%202006-2015%20-%20BIO,%20Biomedtracker,%20Amplion%202016.pdf

Page 9 of the pdf indicates that for all indications, the success rate of Phase 3 to NDA/BLA is 58.1%, and for neurology the rate is 57.4%.

That is what I was referring to.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News